NSME header

Frederik Barkhof

United Kingdom
Frederik Barkhof
Frederik Barkhof

United Kingdom

Expert biography

Frederik Barkhof received his MD from Vrije Universiteit (VU) University, Amsterdam, The Netherlands in 1988 and completed his PhD thesis in 1992, for which he received the Philips Prize for Radiology (1992) and the Lucien Appel Prize for Neuroradiology (1994) from the European Society of Neuroradiology. Since 2001, he has served as a full Professor in Neuroradiology at the Department of Radiology and Nuclear Medicine, VU University Medical Centre. In 2015, he was appointed as full Professor of Neuroradiology at the Institutes of Biomedical Engineering and Neurology, University College London, London, UK, where he works to develop novel imaging techniques. In 2018, he received the John Dystel Prize from the American Academy of Neurology and National Multiple Sclerosis Society for his unique contributions to multiple sclerosis (MS) research. In 2019, he became a senior fellow of the International Society for Magnetic Resonance in Medicine.

Prof. Barkhof was the chairman of the Dutch Society of Neuroradiology and the Magnetic Resonance Imaging in MS study group for many years. He is leading the Queen Square MS Centre Trial Unit, which is involved in the analysis of multicentre drug trials. He serves on the editorial boards of Radiology, Brain, Multiple Sclerosis Journal, Neuroradiology and Neurology. Additionally, he is a fellow of the Royal College of Radiologists.

His research interests focus on white matter disease, ageing, and dementia and glioma. He has authored or co-authored more than 1100 papers and has a h-index of 167 (Google Scholar) and is listed among the 3000 World's Most Influential Scientific Minds by Thomson-Reuters. He is the author of the books Neuroimaging in Dementia, Clinical Applications of Functional Brain MRI and Clinical Neuroradiology – The ESNR Textbook.

Prof. Barkhof has received over 25 million euros of grant money from various national and international funding agencies, and performed contract research for all major pharmaceutical companies, with a cumulative contract value greater than 15 million euros. More than 60 PhD students have graduated under his supervision and four of them have subsequently attained a full professorship.

EM-62446 - Date of preparation: May 2021

MORE INFORMATION
You can see my upcoming and previous webinars here.